Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 56
Filtrar
1.
Scand J Rheumatol ; 50(3): 213-217, 2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-33025831

RESUMO

Objectives: Methotrexate (MTX) administered at the dose 10-15 mg/m2 is currently recommended as the first line therapy in most juvenile idiopathic arthritis (JIA) subtypes. Gastrointestinal side effects and hepatotoxicity are the most prevalent manifestations of MTX intolerance, frequently leading to discontinuation of otherwise effective treatment. Genetic variability within solute carrier organic anion transporter family member 1B1 (SLCO1B1), encoding a hepatic MTX membrane transporter, has been associated with high-dose MTX efficacy and toxicity in paediatric patients with acute lymphoblastic leukaemia. The aim of our study was to determine the association between single-nucleotide polymorphisms in the SLCO1B1 gene (rs4149056, rs2306283) on the disease activity and presence of side effects of MTX therapy in patients with JIA.Method: The study recruited 100 children with JIA of all subtypes treated with MTX. Demographic and clinical parameters were collected at the baseline of MTX therapy and on a control visit 4-6 months after starting MTX. Genotyping was performed using genomic DNA isolated from peripheral blood samples.Results: In comparison to wild-type allele, SLCO1B1 rs4149056 CT/CC variant was significantly associated with higher odds ratio of MTX gastrointestinal side effects occurrence (OR=4.55, 95%CI 1.37-15.13; p=0.013). SLCO1B1 rs4149056 TT subjects were more likely than CT/CC individuals to develop hepatotoxicity (17.86% vs 4.76%, p = 0.046).Conclusion: SLCO1B1 rs4149056 may serve as a determinant of MTX treatment toxicity in children with JIA.


Assuntos
Antirreumáticos/efeitos adversos , Artrite Juvenil/tratamento farmacológico , Transportador 1 de Ânion Orgânico Específico do Fígado/genética , Metotrexato/efeitos adversos , Alelos , Antirreumáticos/uso terapêutico , Artrite Juvenil/genética , Criança , Pré-Escolar , Feminino , Genótipo , Humanos , Masculino , Metotrexato/uso terapêutico , Farmacogenética , Polimorfismo de Nucleotídeo Único , Resultado do Tratamento
2.
Br J Dermatol ; 172(4): 1103-10, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25228137

RESUMO

BACKGROUND: Few therapeutic alternatives currently exist in the treatment of papulopustular rosacea (PPR). OBJECTIVES: To demonstrate superiority of once-daily ivermectin 1% cream (IVM 1%) once daily vs. twice-daily metronidazole (MTZ 0·75%) cream, regarding percentage reduction of inflammatory lesions in subjects with moderate to severe PPR. METHODS: In this Phase 3, investigator-blinded, randomized, parallel-group study, subjects received IVM 1% once daily, or MTZ 0·75% twice daily over 16 weeks. Efficacy assessments were inflammatory lesion counts and Investigator's Global Assessment (IGA). Safety assessments included incidence of adverse events (AEs) and local tolerance parameters. Subjects evaluated their disease following a 5-grade scale and completed questionnaires. RESULTS: A total of 962 subjects were randomized to receive IVM 1% (n = 478) or MTZ 0·75% (n = 484). At week 16, IVM 1% was significantly superior to MTZ 0·75% in terms of reduction from baseline in inflammatory lesions (83·0% vs. 73·7%; P < 0.001), observed as early as week 3 (Last Observation Carried Forward, LOCF). IGA results (subjects 'clear' or 'almost clear') also favoured IVM 1%: 84·9% vs. 75·4%, respectively (P < 0.001). Incidence of AEs was comparable between groups and local tolerability was better for IVM 1%. More subjects receiving IVM rated their global improvement as 'excellent' or 'good.' CONCLUSIONS: Ivermectin 1% cream was significantly superior to MTZ 0·75% cream and achieved high patient satisfaction.


Assuntos
Fármacos Dermatológicos/administração & dosagem , Ivermectina/administração & dosagem , Metronidazol/administração & dosagem , Rosácea/tratamento farmacológico , Administração Cutânea , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Fármacos Dermatológicos/efeitos adversos , Feminino , Humanos , Ivermectina/efeitos adversos , Masculino , Metronidazol/efeitos adversos , Pessoa de Meia-Idade , Pomadas , Satisfação do Paciente , Resultado do Tratamento , Adulto Jovem
3.
J Eur Acad Dermatol Venereol ; 27(3): 319-23, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22176586

RESUMO

BACKGROUND: Neovascularization plays an important role in pathogenesis of psoriasis and vascular endothelial growth factor (VEGF) seems to be the main angiogenic factor involved in this disease. Published studies which analysed the role of VEGF gene polymorphism in psoriasis were limited and they received controversial results. Objective The aim of our study was to evaluate the association between -1154 G/A, -460 T/C and +405 G/C polymorphisms and the psoriasis susceptibility and to determine whether this genetic variation influence levels of VEGF protein expression. MATERIALS AND METHODS: One hundred and eighty-nine patients with psoriasis and 215 ethnically matched controls were genotyped using ARMS-PCR and PCR-RFLP methods. VEGF serum levels were assessed in 47 patients and 40 controls using ELISA test. RESULTS: We noted that an increased risk of Type I psoriasis is associated with -1154 G allele (OR = 1.9; P = 0.04), +405 CC (OR = 2.86; P = 0.03) and -460 TT (OR = 1.56; P = 0.05) genotypes and demonstrated that a significantly increased risk of developing disease is related to presence of haplotype GTC among all patients (OR = 1.97; P = 0.001), patients with Type I (OR = 1.87; P = 0.005) and Type II psoriasis (OR = 2.37, P = 0.01). We have found significantly increased serum levels of VEGF in patients with psoriasis compared with those in healthy controls (P = 0.008). Serum levels of VEGF significantly correlated with PASI: r = 0.72, P < 0.00001. Patients with elevated levels of VEGF in the serum showed more frequently: GC genotype (P = 0.04), C allele (P = 0.02) at the locus +405 and TT genotype (P = 0.03) at the locus -460. CONCLUSION: Our results strongly support the role of VEGF gene polymorphism in the pathogenesis of psoriasis.


Assuntos
Predisposição Genética para Doença , Polimorfismo Genético , Psoríase/genética , Fator A de Crescimento do Endotélio Vascular/genética , Adolescente , Adulto , Alelos , Criança , Feminino , Haplótipos , Humanos , Masculino , Pessoa de Meia-Idade , Polônia , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de Restrição
5.
Clin Exp Dermatol ; 36(7): 728-32, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21689145

RESUMO

BACKGROUND: Interleukin (IL)-18 is a pleiotropic cytokine. Synergistically with IL-12, IL-18 promotes immune responses of the T helper type, by enhancing synthesis of interferon-γ and inhibiting IgE production. IL-18 can also enhance production of IL-4 and IL-13 production, and stimulate synthesis of IgE. Moreover, in the presence of IL-3, IL-18 can directly stimulate basophils and mast cells to produce their mediators in an IgE-independent manner. These results indicate a role for IL-18 in the pathogenesis of atopic dermatitis (AD). AIM: To examine the association of serum IL-18 with IgE levels and disease severity in patients with AD. METHODS: ELISA was used to measure IL-18 and total IgE levels in the sera of 67 patients with AD and 50 healthy volunteers. The SCORing Atopic Dermatitis (SCORAD) tool was used to determine the severity of this disease. RESULTS: The mean serum level of IL-18 in study group (155.68 pg/mL) was significantly higher than that of controls. IL-18 was also significantly higher in the sera of the patients with severe AD than in those with milder disease. There was a correlation with IgE and IL-18 levels, as patients who had high IgE levels also had high IL-18 levels, compared with controls. CONCLUSION: IL-18 seems to play an important role in the pathogenesis of AD, but this requires further study. IL-18 could be a useful clinical marker of disease severity in AD.


Assuntos
Dermatite Atópica/sangue , Imunoglobulina E/sangue , Interleucina-18/sangue , Adolescente , Adulto , Criança , Pré-Escolar , Dermatite Atópica/patologia , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Polônia , Índice de Gravidade de Doença , Adulto Jovem
8.
Allergy ; 64(2): 287-94, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19178408

RESUMO

BACKGROUND: Mastocytosis is a heterogenous disease involving mast cells (MC) and their progenitors. Cutaneous and systemic variants of the disease have been reported. In contrast to cutaneous mastocytosis (CM), patients with systemic mastocytosis (SM) are at risk to develop disease progression or a nonMC-lineage haematopoietic neoplasm. Little is known, however, about factors predisposing for the development of SM. One factor may be cytokine regulation of MC progenitors. METHODS: We examined the role of the interleukin-13 (IL-13) promoter gene polymorphism -1112C/T, known to be associated with increased transcription, in mastocytosis using allele-specific polymerase chain reaction method. Serum tryptase and IL-13 levels were determined by immunoassay, and expression of the IL-13 receptor in neoplastic MC by reverse transcription-polymerase chain reaction and flow cytometry. RESULTS: The frequency of the -1112T allele of the IL-13 promoter was significantly higher in patients with SM compared with CM (P < 0.008) and in mastocytosis patients compared with healthy controls (P < 0.0001). Correspondingly, the polymorphism was found to correlate with an elevated serum tryptase level (P = 0.004) and with adult-onset of the disease (P < 0.0015), both of which are almost invariably associated with SM. Serum IL-13 levels were also higher in SM patients compared with CM (P = 0.011), and higher in CT- than in CC carriers (P < 0.05). Finally, we were able to show that neoplastic human MC display IL-13 receptors and grow better in IL-13-containing medium. CONCLUSIONS: The -1112C/T IL-13 gene polymorphism and the resulting 'hypertranscription' may predispose for the development of SM.


Assuntos
Predisposição Genética para Doença , Interleucina-13/sangue , Interleucina-13/genética , Mastocitose Sistêmica/genética , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Alelos , Linhagem Celular Tumoral , Criança , Pré-Escolar , Frequência do Gene , Genótipo , Humanos , Lactente , Interleucina-13/imunologia , Mastocitose Sistêmica/imunologia , Pessoa de Meia-Idade , Polimorfismo Genético , Regiões Promotoras Genéticas , Receptores de Interleucina-13/genética , Receptores de Interleucina-13/imunologia , Receptores de Interleucina-13/metabolismo , Triptases/sangue , Triptases/genética , Triptases/imunologia , Adulto Jovem
9.
Br J Dermatol ; 157(1): 165-7, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17553030

RESUMO

BACKGROUND: Tumour necrosis factor (TNF)-alpha is considered to be an important mediator in the pathogenesis of psoriasis. Increased levels and activity of this cytokine have been observed in blood and skin of patients with psoriasis. As certain allelic variants of the TNF-alpha gene are associated with increased or decreased production of TNF-alpha, the disturbed cytokine balance may be under genetic control. OBJECTIVES: To investigate the potential association of TNF-alpha promoter alleles within subtypes of psoriasis compared with healthy controls in a northern Polish population. METHODS: We analysed 166 patients with psoriasis vulgaris (134 with type I and 32 with type II) and 65 healthy controls. The polymorphisms -238G/A and -308G/A in the promoter region of the TNF-alpha gene were typed using the amplification refractory mutation system-polymerase chain reaction method. RESULTS: We found that the TNF-alpha-308A allele frequency was significantly decreased among patients with early-onset psoriasis in comparison with control subjects (7.5% vs. 15.4%, P = 0.022), whereas in the same patients the frequency of the TNF-alpha-238A allele was significantly increased as compared with the controls (16.8% vs. 3.1%, P = 0.000017, odds ratio 8.79, 95% confidence interval 2.606-29.678). Patients with early-onset psoriasis with -238 genotype GA or AA were found more often among those with age at onset < 25 years in comparison with those with genotype GG (31.7% vs. 9.1%, P = 0.0312). We also found that the mean +/- SD age at onset among -238A carriers was significantly lower in comparison with that associated with the -238GG genotype (13.5 +/- 7.4 vs. 19.2 +/- 9.9 years, P = 0.0132). CONCLUSIONS: Our study confirming the association between -238 G/A TNF-alpha promoter polymorphism and early-onset psoriasis vulgaris in the northern Polish population suggests that the -238A variant may contribute not only to a predisposition to psoriasis vulgaris but also to the disease phenotype.


Assuntos
Polimorfismo Genético/genética , Regiões Promotoras Genéticas/genética , Psoríase/genética , Fator de Necrose Tumoral alfa/genética , Adulto , Idoso , Citocinas/metabolismo , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Polônia/epidemiologia , Psoríase/epidemiologia
10.
Mycoses ; 49(1): 55-9, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16367820

RESUMO

Onychomycosis was considered uncommon in children. This survey was carried out to estimate the frequency of fungal nail infections in children and adolescents (0-18 years of age) attending our clinic in the last decade and gain more insight into the aetiology and clinics of this entity in the paediatric age group. This study is based on data obtained from 2320 children and adolescents suspected of superficial fungal infection. Onychomycosis was diagnosed in 99 cases, representing 19.8% of all mycologically confirmed superficial mycoses (500 cases) in our material. Fingernail onychomycosis was recognized in 52 (10.4%) cases; children under 3 years of age were predominantly involved. Candida albicans was the most common isolated pathogen. Toenail onychomycosis concerned 47 (9,4%) patients; the incidence increased steadily with increasing age. Trichophyton rubrum was the most common aetiological agent with respect to toenail infection followed by T. mentagrophytesvar. interdigitale and T. mentagrophytes var. granulosum. The majority of fungal nail infections were characterized clinically by distal and lateral subungual onychomycosis. The growing trend towards the frequency of toenail and fingernail onychomycosis in children and adolescents was found in the last decade in north Poland. The results of our study show that onychomycosis in prepubertal children is not exceptional and should be considered in differential diagnosis of nail plate disorders.


Assuntos
Dermatoses da Mão/epidemiologia , Onicomicose/epidemiologia , Adolescente , Criança , Pré-Escolar , Dermatoses do Pé/epidemiologia , Inquéritos Epidemiológicos , Humanos , Incidência , Lactente , Recém-Nascido , Polônia/epidemiologia , Especificidade da Espécie , Trichophyton/isolamento & purificação
11.
Clin Exp Dermatol ; 30(6): 702-6, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16197392

RESUMO

Patients with Sézary syndrome (SS) show clonal expansion in the peripheral blood of skin-homing CD4+ T-helper cells expressing cutaneous lymphocyte antigen (CLA). However, an increase of CLA+ CD4+ T cells can also be observed in various inflammatory dermatoses. To facilitate early diagnosis and therapeutic monitoring of SS using flow cytometry, we evaluated the expression of CD7 and CD26 on the CLA+ CD4+ lymphocyte subset. Peripheral lymphocytes from 7 patients with SS, 16 patients with mycosis fungoides (MF) and 11 healthy controls were analysed by flow cytometry for the expression of CD4, CD7, CD26, CLA and CCR4. In addition, a longitudinal study was performed over 16 months in two patients with SS. Absence of CD7 and CD26 on CLA+ CD4+ T cells was highly specific for SS. Importantly, the absence of CD26 on CLA+ CD4+ T cells was very sensitive for SS, at 100% in our patient cohort. The number of CD26- CLA+ CD4+ T cells closely correlated with therapeutic interventions in the longitudinal analysis of two patients over more than 1 year. We conclude that the absence of CD26 expression on skin-homing CLA+ CD4+ T-helper cells is a very sensitive and highly specific parameter for early diagnosis and therapeutic monitoring of patients with SS.


Assuntos
Antígenos CD7/metabolismo , Antígenos CD4/metabolismo , Linfócitos T CD4-Positivos/imunologia , Dipeptidil Peptidase 4/metabolismo , Glicoproteínas de Membrana/metabolismo , Síndrome de Sézary/imunologia , Neoplasias Cutâneas/imunologia , Antígenos de Diferenciação de Linfócitos T , Antígenos de Neoplasias , Biomarcadores , Feminino , Humanos , Masculino , Síndrome de Sézary/diagnóstico
12.
Br J Dermatol ; 152(2): 258-64, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15727636

RESUMO

BACKGROUND: Adhesion molecules and chemokine receptors are involved in tissue-specific homing of T cells to the skin and play an important role in the pathophysiology of cutaneous lymphoma. It has recently been reported that the chemokine CCL27 expressed by keratinocytes attracts lymphocytes bearing the chemokine receptor CCR10. OBJECTIVES: To investigate the expression of CCR4, CCR7 and CCR10 on skin-homing CLA(+) and CD4(+) T cells in the peripheral blood of patients with Sezary syndrome (SS), a rare leukaemic variant of cutaneous T-cell lymphoma. METHODS: Lymphocytes from five patients with SS, six patients with mycosis fungoides and four healthy volunteers were isolated and analysed using flow cytometry. Additionally, the T-cell receptor (TCR)-Vbeta CDR3 regions were cloned and sequenced in two patients. RESULTS: We found that CCR4 is expressed on almost all CLA(+) and CD4(+) memory T cells. Using monoclonal antibodies specific for single TCR-Vbeta chains we identified malignant T cells in four patients with SS. Importantly, we found that most but not all malignant Sezary cells expressed the skin-homing chemokine receptor CCR10. Additionally, we found that a significant proportion of these cells also expressed the lymph node-homing chemokine receptor CCR7. CONCLUSIONS: Our results support the concept that chemokine receptors play an important role in the pathophysiology of SS and suggest that the malignant clone may represent an expansion of skin-homing cutaneous 'central' memory T cells in the peripheral blood of these patients.


Assuntos
Linfócitos T CD4-Positivos/imunologia , Receptores de Quimiocinas/sangue , Síndrome de Sézary/imunologia , Subpopulações de Linfócitos T/imunologia , Adulto , Idoso , Antígenos de Diferenciação de Linfócitos T , Antígenos de Neoplasias , Regiões Determinantes de Complementaridade/genética , Feminino , Citometria de Fluxo/métodos , Humanos , Linfonodos/imunologia , Masculino , Glicoproteínas de Membrana/sangue , Pessoa de Meia-Idade , Micose Fungoide/imunologia , Receptores de Antígenos de Linfócitos T alfa-beta/genética , Receptores CCR10 , Receptores CCR4 , Receptores CCR7 , Neoplasias Cutâneas/imunologia
13.
Am J Med Genet ; 100(3): 191-7, 2001 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-11343303

RESUMO

Anhidrotic ectodermal dysplasia (EDA) is caused by mutations in the EDA gene encoding ectodysplasin A, a member of the TNF ligand superfamily involved in the communication between the cells. The structure of the EDA gene was investigated in three patients exhibiting clinical symptoms of EDA in an attempt to correlate the molecular findings with the phenotype of the patients. Genomic DNA was analyzed by single stranded conformation polymorphism (SSCP) followed by direct sequencing. In one of the patients, as well as in his heterozygous mother and sister, a single T insertion was evidenced in exon 3 between nucleotides 713 and 714 that changed Lys codon (AAA) into a termination codon TAA (Lys158Ter). In the other patient, A1321T transversion was demonstrated. The same mutation was found in his heterozygous mother and resulted in a change of Ileu360Asn that might generate an additional glycosylation site. In the third patient an A1285G transition was revealed. This mutation that originated de novo was localized in a region that is highly conserved in TNF ligand family and caused substitution of Ala349Thr. Localization of the mutations in the extracellular domain of ectodysplasin A suggested that the primary cause of EDA is a defect in communication between the cells responsible for the development of skin appendages. Despite a different character and localization of the mutations, no apparent correlation between phenotype and genotype of the patients was evidenced. Some differences in the patients' phenotype were observed.


Assuntos
Displasia Ectodérmica/genética , Proteínas de Membrana/genética , Cromossomo X , Criança , Pré-Escolar , Ectodisplasinas , Éxons , Feminino , Ligação Genética , Genótipo , Humanos , Lactente , Masculino , Mutação , Linhagem , Fenótipo , Mutação Puntual , Reação em Cadeia da Polimerase , Polimorfismo Conformacional de Fita Simples , Receptores do Fator de Necrose Tumoral , Análise de Sequência de DNA
14.
Minerva Cardioangiol ; 49(2): 107-14, 2001 Apr.
Artigo em Italiano | MEDLINE | ID: mdl-11292954

RESUMO

OBJECTIVE: To determine the increase in healing rate of venous ulcer in patients receiving a micronised purified flavonoid fraction (MPFF) as supplementation to standard local care. DESIGN: A randomised, open, controlled, multicentre study. SETTING: Departments of Dermatology and University Outpatients Clinics. PATIENTS: One hundred and forty patients with chronic venous insufficiency and venous ulcers. INTERVENTION: PATIENTS received standard compressive therapy plus external treatment alone or 2 tablets of MPFF daily in addition to the above treatment for 24 weeks. MAIN OUTCOME MEASURE: Healing of ulcers and their reduction in size after 24 weeks of treatment. RESULTS: The percentage of patients whose ulcers healed completely was found to be markedly higher in those receiving MPFF in addition to standard external and compressive treatment than in those treated with conventional therapy alone (46.5% vs 27.5%; p<0.05. OR=2.3, 95% CI 1.1-4.6). Ulcers with diameters <3 cm were cured in 71% of patients in the MPFF group and in 50% of patients in the control group, whereas ulcers between 3 and 6 cm in diameter were cured in 60% and 32% of patients (p<0.05), respectively. The mean reduction in ulcer size was also found to be greater in patients treated with MPFF (80%) than in the control group (65%) (p<0.05). The cost-effectiveness ratio (cost per healed ulcer) in the MPFF group was 1026.2 compared with 1871.8 in the control group. CONCLUSIONS: These results indicate that MPFF significantly improves the cure rate in patients with chronic venous insufficiency.


Assuntos
Flavonoides/uso terapêutico , Úlcera da Perna/tratamento farmacológico , Idoso , Feminino , Humanos , Masculino , Tamanho da Partícula
15.
Cutis ; 67(3): 197-200, 203-4, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11270292

RESUMO

A case of cutaneous T-cell lymphoma (CTCL) in a 22-month-old patient is discussed, emphasizing the importance of screening for CTCL even in very young patients with atypical symptoms of eczema, atopic dermatitis, or parapsoriasis. The clinical, histologic, and immunologic diagnostics can now be supported by molecular methods; therefore, patients at the earlier stages of CTCL can be diagnosed and treated with good results.


Assuntos
Linfoma Cutâneo de Células T/diagnóstico , Neoplasias Cutâneas/diagnóstico , Adolescente , Adulto , Braço , Nádegas , Diagnóstico Diferencial , Humanos , Linfoma Cutâneo de Células T/tratamento farmacológico , Linfoma Cutâneo de Células T/patologia , Masculino , Terapia PUVA , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/patologia , Coxa da Perna
16.
Dermatol Surg ; 25(11): 904-7, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10594607

RESUMO

BACKGROUND: Advanced, histologically aggressive basal cell carcinomas (BCCs) of eyelids are difficult to eradicate. OBJECTIVE: To describe a case of BCC of both eyelids and lateral canthus and the reconstruction procedures used. METHODS: A two-stage reconstruction procedure was used. First, only mobilization of the forniceal conjunctiva and the musculocutaneous flap technique were used. The because of shortage and insufficiency of the upper eyelid the flap/graft technique was performed. A conchal complex cartilage-perichondrial graft was selected. RESULTS: The described procedure resulted in a very good functional and aesthetic outcome.


Assuntos
Carcinoma Basocelular/cirurgia , Pálpebras/cirurgia , Procedimentos de Cirurgia Plástica/métodos , Neoplasias Cutâneas/cirurgia , Transplante de Pele/métodos , Retalhos Cirúrgicos , Idoso , Carcinoma Basocelular/diagnóstico , Cartilagem/transplante , Estética , Feminino , Seguimentos , Humanos , Índice de Gravidade de Doença , Neoplasias Cutâneas/diagnóstico , Resultado do Tratamento
17.
Cutis ; 61(3): 137-41; quiz 152, 1998 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9538954

RESUMO

Multifocal Kaposi's sarcoma in a patient with chronic myeloid leukemia treated with busulfan, a cytostatic and suppressive drug, is reviewed. After five years of treatment, during which temporary remissions occurred, the patient experienced a relapse of leukemia and a considerable immune deficiency. This was expressed by a decrease in the ratio of CD4/CD8 lymphocytes in the peripheral blood. The relation of Kaposi's sarcoma with leukemia, as well as with the state of immunity in this case, does not evoke any doubts. Verification of oncologic treatment brought about a remission of leukemia, an improvement in the patient's immune state, as well as an inhibition of new foci of the Kaposi's sarcoma in the skin in the course of a few months of follow-up evaluation.


Assuntos
Bussulfano/efeitos adversos , Imunossupressores/efeitos adversos , Leucemia Mielogênica Crônica BCR-ABL Positiva/tratamento farmacológico , Neoplasias Penianas/etiologia , Sarcoma de Kaposi/etiologia , Idoso , Relação CD4-CD8 , Diagnóstico Diferencial , Evolução Fatal , Humanos , Hospedeiro Imunocomprometido , Leucemia Mielogênica Crônica BCR-ABL Positiva/imunologia , Masculino , Neoplasias Penianas/patologia , Neoplasias Penianas/terapia , Sarcoma de Kaposi/patologia , Sarcoma de Kaposi/terapia
18.
Przegl Lek ; 55(10): 520-3, 1998.
Artigo em Polonês | MEDLINE | ID: mdl-10224865

RESUMO

Arthritis psoriatica has been known for over 160 years, however, not long ago it became a separate nosologic unit. In 1964 American Rheumatological Society introduced the name arthritis psoriatica, which is obligatory nowadays. It was thought in the beginning that the inflammation may coexist with psoriasis accidentally only, whereas epidemiological studies, clinical observations and serologic data excluded such a simple relation. Since the international diagnostic criteria were established and also the rheumatoid factor was discovered it has been clear there's a direct relation between arthritis psoriatica and dermatologic changes of a psoriasis type. Therefore it is a disease where rheumatology and dermatology meet with each other. The aim of our study was to collect the knowledge about the diagnosis of arthritis psoriatica.


Assuntos
Artrite Psoriásica/diagnóstico , Humanos
19.
Dermatol Surg ; 23(11): 1075-9, 1997 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9391568

RESUMO

BACKGROUND: The upper lip is an important esthetic unit of the face and its reconstruction is a big challenge to the dermatosurgeon. OBJECTIVE: The aim of the paper is to present results of upper lip reconstruction for moderately sized defects with single island subcutaneously pedicled flaps, or in combination with additional local flaps. METHODS: Thirteen patients were operated upon mostly for malignant skin neoplasms. Defects of skin only were covered with island flaps planned individually to fit esthetic units of the face. Defects in skin and vermillion were covered with island flaps, and additionally and independently with flaps that reconstructed the vermilion. RESULTS: The healing process was in all the cases but one (partial flap necrosis) free of complications. Follow-up results were also very good functionally and esthetically.


Assuntos
Carcinoma Basocelular/cirurgia , Carcinoma de Células Escamosas/cirurgia , Neoplasias Labiais/cirurgia , Procedimentos de Cirurgia Plástica , Neoplasias Cutâneas/cirurgia , Retalhos Cirúrgicos , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma Basocelular/patologia , Carcinoma de Células Escamosas/patologia , Feminino , Humanos , Neoplasias Labiais/patologia , Masculino , Pessoa de Meia-Idade , Neoplasias Cutâneas/patologia , Cirurgia Plástica/métodos
20.
Arch Immunol Ther Exp (Warsz) ; 44(4): 265-9, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-9017168

RESUMO

The purpose of the study was to classify psoriasis vulgaris basing on HLA phenotype and the age of onset of the disease. One hundred fifteen psoriatic patients were included into the study and divided into two groups: group I--with early onset (< 40 years) and group II--with late onset (> or = 40 years). Each group was subclassified according to Cw6 antigen expression: IA-Cw(6+)--early onset, IB-Cw(6-)--early onset, IIA-Cw(6+)--late onset, IIB-Cw(6-)--late onset. HLA class I antigen typing was performed in each of 115 subjects using the microlymphocytotoxicity test. HLA class II antigen typing was also performed in 20 randomly selected patients by means of the two-step microlymphocytotoxicity test. The occurrence Cw6, B13, B17 antigens was significantly increased in psoriatic groups in comparison with a control population. No difference between the groups was found with respect to class II antigen frequency. Cw6, B13 and B17 were the most specific markers for psoriasis with the early onset, whereas B27, Cw2, B44 and Cw5 seemed to be associated with the late type of the disease.


Assuntos
Antígenos HLA/análise , Psoríase/epidemiologia , Adolescente , Adulto , Idade de Início , Idoso , Criança , Pré-Escolar , Suscetibilidade a Doenças , Feminino , Frequência do Gene , Antígenos HLA-B/análise , Antígenos HLA-C/análise , Humanos , Masculino , Pessoa de Meia-Idade , Polônia/epidemiologia , Psoríase/genética , Psoríase/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...